Literature DB >> 3086319

Preparation and characterization of FAD-dependent NADPH-cytochrome P-450 reductase.

G P Kurzban, H W Strobel.   

Abstract

NADPH-cytochrome P-450 reductase releases FAD upon dilution into slightly acidic potassium bromide. Chromatography on high performance hydroxylapatite resolved the FAD-dependent reductase from holoreductase. The FAD dependence was matched by a low FAD content, with the ratio of FAD to FMN as low as 0.015. The aporeductase had negligible activity toward cytochrome c, ferricyanide, menadione, dichlorophenolindophenol, nitro blue tetrazolium, and an analogue of NADP, acetylpyridine adenine dinucleotide phosphate. A 4-min incubation in FAD reconstituted from one-half to all of the enzyme activity, as compared to the untreated reductase, depending upon the substrate. After a 2-h reconstitution, the reductase eluted from hydroxylapatite at the same location in the elution profile as did the untreated holoreductase. The reconstituted reductase had little flavin dependence, was nearly equimolar in FMN and FAD, and had close to the specific activity, per mol of flavin, of untreated reductase. The dependence upon FAD implies that FMN is not a competent electron acceptor from NADPH. Thus, the FAD site must be the only point of electron uptake from NADPH.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086319

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Thermal inactivation of the reductase domain of cytochrome P450 BM3.

Authors:  Arvind P Jamakhandi; Brandon C Jeffus; Vandana R Dass; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2005-07-15       Impact factor: 4.013

2.  Stabilization of the Reductase Domain in the Catalytically Self-Sufficient Cytochrome P450BM3 by Consensus-Guided Mutagenesis.

Authors:  Gloria Saab-Rincón; Hanan Alwaseem; Valeria Guzmán-Luna; Leticia Olvera; Rudi Fasan
Journal:  Chembiochem       Date:  2018-02-12       Impact factor: 3.164

3.  Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.

Authors:  Djemel Hamdane; Chuanwu Xia; Sang-Choul Im; Haoming Zhang; Jung-Ja P Kim; Lucy Waskell
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

4.  Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.

Authors:  Michel Kranendonk; Christopher C Marohnic; Satya P Panda; Maria Paula Duarte; José Santos Oliveira; Bettie Sue Siler Masters; José Rueff
Journal:  Arch Biochem Biophys       Date:  2008-04-20       Impact factor: 4.013

5.  Purification and characterization of a soybean flour-inducible ferredoxin reductase of Streptomyces griseus.

Authors:  M Ramachandra; R Seetharam; M H Emptage; F S Sariaslani
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

6.  Zinc finger nuclease knock-out of NADPH:cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependence.

Authors:  Jiechuang Su; Yongchuan Gu; Frederik B Pruijn; Jeff B Smaill; Adam V Patterson; Christopher P Guise; William R Wilson
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

7.  Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.

Authors:  Freeborn Rwere; Chuanwu Xia; Sangchoul Im; Mohammad M Haque; Dennis J Stuehr; Lucy Waskell; Jung-Ja P Kim
Journal:  J Biol Chem       Date:  2016-05-09       Impact factor: 5.157

8.  Selective Targeting of Heme Protein in Cytochrome P450 and Nitric Oxide Synthase by Diphenyleneiodonium.

Authors:  John T Szilagyi; Vladimir Mishin; Diane E Heck; Yi-Hua Jan; Lauren M Aleksunes; Jason R Richardson; Ned D Heindel; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2016-02-14       Impact factor: 4.849

9.  Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase.

Authors:  Sameer S Udhane; Shaheena Parween; Norio Kagawa; Amit V Pandey
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.